Yashu Dhamija
Allergy & Immunology · Cincinnati, OHNPI 1295267599
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,562 of the $5,079 with a category attached, or 70.1%. 12 manufacturers reported payments, led by Sanofi US Services Inc. at 35.7% of the total. 2025 is the largest year on record at $4,322, more than ten times the $306 reported in 2022.
Across 30 payments — averaging $169.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$2K
- Invivyd Inc$2K
- AstraZeneca$460
- GSK$304
- Takeda Pharmaceuticals U.S.A., Inc.$170
- Novartis$129
- plus $454 from 6 others
What the payments were for
- Consulting fees$3,56270%
- Food & beverage$1,51730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 1 | $1,812 |
| Invivyd Inc | 1 | $1,750 |
| AstraZeneca | 8 | $460 |
| GSK | 6 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $170 |
| Novartis | 4 | $129 |
| Sanofi | 3 | $124 |
| Biocryst US Sales Co., LLC | 1 | $123 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $42 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,079 in reported general payments places this provider in the 60th percentile of 128 allergy & immunology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 15 | $91,630 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $83,312 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 36 | $74,827 |
| XhanceFluticasone Propionate | 11 | $12,429 |
| Spiriva RespimatTiotropium Bromide | 18 | $11,660 |
| OdactraMite,d.Farinae-D.Pteronyssinus | 17 | $6,050 |
| Epinephrine | 21 | $4,287 |
| Azelastine Hcl | 62 | $2,618 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,040 |
| Levocetirizine Dihydrochloride | 22 | $1,963 |
| Famotidine | 67 | $1,387 |
| Triamcinolone Acetonide | 32 | $1,039 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $954 |
| Ipratropium Bromide | 29 | $739 |
| Doxepin Hcl | 33 | $710 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Cincinnati
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Gordon MyersCincinnati$346K
- David BernsteinCincinnati$93K
- Sheharyar DurraniCincinnati$87K
- Joshua BernsteinCincinnati$18K
- David TapkeCincinnati$17K
- Jeffrey RaubCincinnati$14K
- Juan AboniaCincinnati$12K
- John SeyerleCincinnati$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.